CHINA PHARMA HOLDINGS, INC. Research And Development Expense

Quick Answer

CHINA PHARMA HOLDINGS, INC. reported Research And Development Expense of $283.9 thousand for the year ending 2024.

  • CHINA PHARMA HOLDINGS, INC. showed an increase of +18.3% in Research And Development Expense from 2023 to 2024.
  • This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2012 to 2024 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2012 to 2024), CHINA PHARMA HOLDINGS, INC.'s Research And Development Expense has declined by 35.3%.
  • Historical annual values: Fiscal year 2024: $283.9 thousand | Fiscal year 2023: $240.1 thousand | Fiscal year 2022: $185.9 thousand | Fiscal year 2021: $319.0 thousand | Fiscal year 2020: $378.0 thousand | Fiscal year 2019: $229.6 thousand | Fiscal year 2018: $172.4 thousand | Fiscal year 2017: $90.5 thousand | Fiscal year 2016: $366.0 thousand | Fiscal year 2015: $961.9 thousand | Fiscal year 2014: $2.80 million | Fiscal year 2013: $1.68 million | Fiscal year 2012: $438.7 thousand.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: